Full article: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease
![Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00702-009-0344-4/MediaObjects/702_2009_344_Fig1_HTML.gif)
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink
![PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42029925/mini_magick20190218-15098-1qujxso.png?1550499289)
PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu
![Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program](https://www.frontiersin.org/files/Articles/1036068/fneur-13-1036068-HTML/image_m/fneur-13-1036068-g001.jpg)
Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
![Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/270172/f/1.png)
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
![PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series](https://i1.rgstatic.net/publication/38012326_Levodopacarbidopaentacapone_20050200_mg_StalevoR_200_in_the_treatment_of_Parkinson's_disease_A_case_series/links/545c259c0cf2f1dbcbcb0e68/largepreview.png)
PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series
![PDF) Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar (R)/Prolopa (R) PDF) Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar (R)/Prolopa (R)](https://i1.rgstatic.net/publication/236337142_Pharmaceutical_quality_of_seven_generic_LevodopaBenserazide_products_compared_with_original_Madopar_RProlopa_R/links/0deec52b17df1c3564000000/largepreview.png)
PDF) Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar (R)/Prolopa (R)
![PDF) Comparative Bioavailability of 2 Tablet Formulations of Levodopa/ Benserazide in Healthy, Fasting Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study PDF) Comparative Bioavailability of 2 Tablet Formulations of Levodopa/ Benserazide in Healthy, Fasting Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study](https://i1.rgstatic.net/publication/51186451_Comparative_Bioavailability_of_2_Tablet_Formulations_of_LevodopaBenserazide_in_Healthy_Fasting_Volunteers_A_Single-Dose_Randomized-Sequence_Open-Label_Crossover_Study/links/5cec59f2458515026a612799/largepreview.png)
PDF) Comparative Bioavailability of 2 Tablet Formulations of Levodopa/ Benserazide in Healthy, Fasting Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
![Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa](https://www.mdpi.com/molecules/molecules-27-08614/article_deploy/html/images/molecules-27-08614-g001-550.jpg)
Molecules | Free Full-Text | Electrochemical Sensor Based on Multi-Walled Carbon Nanotubes and N-Doped TiO2 Nanoparticles for Voltametric Simultaneous Determination of Benserazide and Levodopa
![PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study](https://i1.rgstatic.net/publication/279232240_L-Dopa_Pharmacokinetic_Profile_with_Effervescent_MelevodopaCarbidopa_versus_Standard-Release_LevodopaCarbidopa_Tablets_in_Parkinson's_Disease_A_Randomised_Study/links/564b21a408ae44e7a28f16dc/largepreview.png)